AUSTIN (Nexstar) — A program designed to conduct drug development clinical trials for a psychedelic drug in Texas hit a road bump after the state could not find a drug company to help develop a ...

The companies developing new weight-loss medicines have a problem: the balance of power has shifted, and patients are bailing out of their clinical trials. People who don’t lose weight can quickly ...

EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”, the “Company”) an innovative clinical-stage biotechnology company focused on developing transformative treatments for chronic inflammatory ...

The US Food and Drug Administration (FDA) issued revised final guidance to assist sponsors, investigators, and institutional review boards conducting clinical trials during disasters and public heath ...

The future of cancer drug research just might be in Omaha, Nebraska, between a Panda Express and a Mattress Firm. A big draw is speed: Nordquist says he can open a trial in as little as two weeks, ...

On April 13, 2026, the US Food and Drug Administration (FDA) announced that it recently sent messages to more than 2,200 medical product companies ...

Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $1.4 million grant to Erin Barr, M.D., a clinician of pediatric hematology/oncology and researcher in the School of Medicine at ...

India's clinical research industry is recovering, but first-in-human studies still face caution. That gap could shape how ...